The Editorial, which ties in with a Seminar on hypertension, says: “Despite very effective and cost-effective treatments, target blood pressure levels are very rarely reached, even in countries where cost of medication is not an issue. Many patients still believe that hypertension is a disease that can be cured, and stop or reduce medication when blood pressure levels fall.”
The risk of becoming hypertensive for a person in a developed country exceeds a “staggering” 90%, and the increasingly common combination and interaction of hypertension with obesity, diabetes and hyperlipidaemia, if left untreated for too long, leads to cardiovascular disease, stroke, renal failure and death.
The disease burden of hypertension is expected to massively increase in the coming years. In 2000, the estimated number of adults living with high blood pressure was 972 million; this is expected to increase to 1.56 billion by 2025. The Editorial says: “Lifestyle factors, such as physical inactivity, a salt-rich diet with high processed and fatty foods, and alcohol and tobacco use, are at the heart of this increased disease burden, which is spreading at an alarming rate from developed countries to emerging economies, such as India and China.”
The Editorial concludes: “Physicians need to convey the message that hypertension is the first, and easily measurable, irreversible sign that many organs in the body are under attack. Perhaps this message will make people think more carefully about the consequences of an unhealthy lifestyle and give preventative measures a real chance.”
The Seminar, authored by Dr Franz Messerli, Division of Cardiology, St Luke’s-Roosevelt Hospital Center, Columbia University, New York and colleagues, takes a detailed look at hypertension, its underlying causes and associated risk factors. The authors state that neither beta-blockers nor thiazide diuretics should be used as first line therapy in uncomplicated hypertension.
They conclude: “Most hypertensive patients need two or more drugs for blood-pressure control and concomitant statin treatment for risk factor reduction. Despite the availability of effective and safe antihypertensive drugs, hypertension and its concomitant risk factors remain uncontrolled in most patients.”
Tony Kirby | alfa
Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy